Incidence of JC-virus replication after rituximab therapy in solid-organ transplant patients.

Nassim Kamar; Catherine Mengelle; Lionel Rostaing

doi:10.1111/j.1600-6143.2008.02499.x

Journal articles

Incidence of JC-virus replication after rituximab therapy in solid-organ transplant patients.

Nassim Kamar ^{1, 2} Catherine Mengelle ^{3, 4} Lionel Rostaing ^{1, 4}

1 Service de Néphrologie - Hypertension Artérielle Dialyse - Transplantation

2 I2MR - Institut de médecine moléculaire de Rangueil

3 Laboratoire de Virologie [Toulouse]

4 CPTP - Centre de Physiopathologie Toulouse Purpan ex IFR 30 et IFR 150

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Human health and pathology / Urology and Nephrology

Complete list of metadatas

https://www.hal.inserm.fr/inserm-00408706
Contributor : Marie Francoise Simon <>
Submitted on : Friday, July 31, 2009 - 4:34:57 PM
Last modification on : Tuesday, February 18, 2020 - 3:32:02 PM

Incidence of JC-virus replication after rituximab therapy in solid-organ transplant patients.

Links full text

Identifiers

Collections

Citation

Export

Metrics

131

Incidence of JC-virus replication after rituximab therapy in solid-organ transplant patients.

Links full text

Identifiers

Collections

Citation

Export

Share

Metrics

131